deborah layton
IQVIA (United Kingdom)
London, United Kingdom
Associate Editor
Vaccine Safety and Regulation
IQVIA (United Kingdom)
London, United Kingdom
Associate Editor
Vaccine Safety and Regulation
Semmelweis University
Budapest, Hungary
Associate Editor
Respiratory Drug Safety
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Associate Editor
Cardiovascular Drug Safety
University of Florida
Gainesville, United States
Associate Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Mexican Social Security Institute
Mexico City, Mexico
Associate Editor
Vaccine Safety and Regulation
Universidade Nove de Julho
São Paulo, Brazil
Associate Editor
Rheumatic Drug Safety
School of Pharmacy, Faculty of Life Sciences, University College London
London, United Kingdom
Associate Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Università telematica San Raffaele
Rome, Italy
Associate Editor
Substance-Based Medical Devices
Harvard Pilgrim Health Care, Harvard Medical School
Boston, United States
Associate Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Cardiology unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
Bologna, Italy
Associate Editor
Cardiovascular Drug Safety
The University of Manchester
Manchester, United Kingdom
Associate Editor
Respiratory Drug Safety
School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem
Jerusalem, Israel
Associate Editor
Maternal-Fetal Medicine
Faculty of Pharmacy, University of Coimbra
Coimbra, Portugal
Associate Editor
Advanced Methods in Pharmacovigilance and Pharmacoepidemiology
Sefako Makgatho Health Sciences University
Pretoria, South Africa
Associate Editor
Vaccine Safety and Regulation
Integrated University Hospital Verona
Verona, Italy
Associate Editor
Respiratory Drug Safety
Clinic of Pulmonology, Clinical Center of Serbia, University of Belgrade
Belgrade, Serbia
Associate Editor
Respiratory Drug Safety